Author

A. Penson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Hayashi· 1 shared A. Heyde· 1 shared A. P. Makohon-Moore· 1 shared A. Raza· 1 shared A. Strillacci· 1 shared B. Houck-Loomis· 1 shared B. Liu· 1 shared B. S. Taylor· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hayashi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ERα-LBD, a novel isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance

A. Strillacci, P. Sansone, V. R. Rajasekhar, M. Turkekul, V. Boyko, F. Meng, B. Houck-Loomis, D. Brown, M. F. Berger, R. C. Hendrickson, Q. Chang, E. de Stanchina, F. Pareja, J. S. Reis-Filho, R. Segu Rajappachetty, , J. Bromberg

The paper identifies ER-LBD, a novel estrogen receptor alpha isoform, which promotes breast cancer growth and resistance to endocrine therapy.

bioRxiv · Oct 14, 2021 · PreprintCancer Biology

SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes

J. L. Manley, Y. K. Lieu, Z. Liu, X. Wei, A. Penson, J. Zhang, X. An, R. Rabadan, A. Raza, S. Mukherjee

This study identifies SF3B1 mutations causing anemia in MDS by inducing missplicing of MAP3K7, leading to reduced p38 MAPK activity and disrupted erythroid differentiation.

bioRxiv · Jun 24, 2020Cancer Biology

Evolutionary Origins of Recurrent Pancreatic Cancer

H. Sakamoto, M. Attiyeh, J. Gerold, A. P. Makohon-Moore, A. Hayashi, J. Hong, R. Kappagantula, L. Zhang, J. Melchor, J. Reiter, A. Heyde, C. Bielski, A. Penson, D. Chakravarty, E. O'Reilly, , C. A. Iacobuzio-Donahue

This study identifies genetic features of recurrent pancreatic cancer through sequencing and finds that treatment-induced genetic changes and potential second primary tumors influence recurrence.

bioRxiv · Oct 31, 2019Cancer Biology